Skip To Main Content

Menu closed

Login / Register
Medical Home
Medical Education
Independent Medical Education
Contact Us

You are now leaving the Lilly Medical Education website

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to Lilly Medical Education.

Search Education Resources (type in keywords)

Mode of Disease - Bruton Tyrosine Kinase (BTK) in B Cell Malignancies

This short video provides an overview of the role of BTK inhibition in B cell malignancies.

Date of Last Review: August 2, 2024

Document Number: VV-MED-162377

Skip To Playlist

Mode of Disease - Bruton Tyrosine Kinase (BTK) in B Cell Malignancies is now playing

0:37

Related Resources

Understanding Bruton’s Tyrosine Kinase Pathway Inhibition in B-Cell Malignancies

This slide deck provides information on covalent and non-covalent (reversible) BTK inhibition in B-cell malignancies, and a growing unmet need of resistance to covalent BTK inhibition.

Understanding Non-Covalent (Reversible) Bruton Tyrosine Kinase (BTK) Inhibition

This slide deck provides a deeper dive on non-covalent (reversible) BTK inhibition in B-cell malignancies, and a growing unmet need of resistance to covalent BTK inhibition.

Understanding Mechanisms of BTK Inhibition in CLL

The slide deck for HCPs will provide an understanding of mechanisms of Bruton's tyrosine kinase inhibition in CLL.

Importance of Targeting Bruton's Tyrosine Kinase Pathway in Chronic Lymphocytic Leukemia

Infographic for HCPs reviewing BTK inhibition and pharmacologic properties for covalent and non-covalent BTK inhibitors.

Please rate your satisfaction with the content on the following statements:

Very Dissatisfied

Dissatisfied

Neutral

Satisfied

Very Satisfied

Credibility of information

Credibility of information

Relevance of the information to my needs

Relevance of the information to my needs

Confidence to implement the learnings in my clinical practice

Confidence to implement the learnings in my clinical practice

Please rate your satisfaction with the content on the following statements:

Credibility of information

Credibility of information

Very Satisfied

Very Dissatisfied

Relevance of the information to my needs

Relevance of the information to my needs

Very Satisfied

Very Dissatisfied

Confidence to implement the learnings in my clinical practice

Confidence to implement the learnings in my clinical practice

Very Satisfied

Very Dissatisfied

Copyright
Terms of Use
Privacy Statement
Consumer Health Privacy Notice
Accessibility Statement
Sitemap

To speak to customer support:
Call (XXX) XXX-XXXX

This site is intended for US Healthcare Professionals only.

4.4.41 12/2024 | GLOOTH00001 04/2015 | © Lilly USA, LLC 2024. All rights reserved.

Product names listed above are trademarks or registered trademarks owned by or licensed to Eli Lilly and Company, its subsidiaries, or affiliates

Your Privacy Choices

Cookie Settings